Roberto D. Polakiewicz
Impact in
- Molecular Biology top 0.5%
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
- Metabolism, Diabetes, and Cancer
- Protein Kinase Regulation and GTPase Signaling
- Protein Degradation and Inhibitors
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
- Hematology 15
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 6
- Genetics 11
- Co-authors
- Michael J. CombNahum SonenbergAnne‐Claude GingrasSteven P. GygiBrian RaughtRuedi AebersoldA. John RushAilan Guo
- Journals
- Blood (9 papers)Journal of Biological Chemistry (7 papers)Molecular and Cellular Biology (5 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Roberto D. Polakiewicz
68 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 6.7k
- Cancer Research 1.3k
- Hematology 764
- Genetics 606
- Oncology 1.4k
Countries citing papers authored by Roberto D. Polakiewicz
This map shows the geographic impact of Roberto D. Polakiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto D. Polakiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto D. Polakiewicz more than expected).
Fields of papers citing papers by Roberto D. Polakiewicz
This network shows the impact of papers produced by Roberto D. Polakiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto D. Polakiewicz. The network helps show where Roberto D. Polakiewicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto D. Polakiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2015 | 23 | |
| 3 | 2012 | 32 | |
| 4 | 2012 | 130 | |
| 5 | 2011 | 188 | |
| 6 | 2008 | 98 | |
| 7 | 2007 | 173 | |
| 8 | 2005 | 84 | |
| 9 | 2005 | 83 | |
| 10 | 2004 | 79 | |
| 11 | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells Hit paper breakdown → | 2004 | 913 |
| 12 | 2002 | 77 | |
| 13 | Hierarchical phosphorylation of the translation inhibitor 4E-BP1 Hit paper breakdown → | 2001 | 707 |
| 14 | 2001 | 49 | |
| 15 | Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism Hit paper breakdown → | 1999 | 1063 |
| 16 | 1998 | 120 | |
| 17 | 1995 | 13 | |
| 18 | 1994 | 22 | |
| 19 | 1991 | 24 | |
| 20 | 1990 | 8 |
About Roberto D. Polakiewicz
Roberto D. Polakiewicz is a scholar working on Hematology, Genetics, Cellular and Molecular Neuroscience, Molecular Biology and Developmental Neuroscience, having authored 69 papers that have together received 9.1k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (15 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Receptor Mechanisms and Signaling (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Glycosylation and Glycoproteins Research (6 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Molecular Biology (6.7k citations), Cancer Research (1.3k citations), Hematology (764 citations), Genetics (606 citations) and Oncology (1.4k citations). Roberto D. Polakiewicz has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Michael J. Comb, Nahum Sonenberg, Anne‐Claude Gingras, Steven P. Gygi, Brian Raught, Ruedi Aebersold, A. John Rush, Ailan Guo, Kimberly A. Lee and Robert T. Abraham. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular and Cellular Biology, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.